Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 7, 2026

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections
16:56

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections

Published on: August 30, 2014

Sublingual specific immunotherapy.

Ralph Mösges1, Eelaf El Hassan, Desiderio Passàli

  • 1Institute of Medical Statistics, Informatics and Epidemiology, Cologne University Hospital, Cologne 50931, Germany. ralph@mosges.com

Discovery Medicine
|November 2, 2010
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sustained Clinical Improvement in Birch Pollen Allergy After Two Pre-Seasonal Short Courses of Allergen-Specific Immunotherapy: A Long-Term Open-Label Extension Study.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2026
Same author

Irreversible Electroporation for Tonsillar Ablation in Adults.

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery·2026
Same author

Meta-Analysis on the Harm of Systemic Glucocorticosteroids in Inflammatory Upper Airway Disease and Asthma: An EAACI Task Force.

Allergy·2026
Same author

Trends and Patterns for the Use of Herbal Medicinal Products for Gynaecological Ailments.

Phytotherapy research : PTR·2026
Same author

The Diabetic Nose: A Narrative Review of Rhinologic Involvement in Diabetes (1973-2025).

Journal of clinical medicine·2026
Same author

Allergen Immunotherapy with Depigmented-Polymerised Cat Allergoid Is Safe and Well-Tolerated in Patients with Allergic Rhinitis/Rhinoconjunctivitis.

Journal of clinical medicine·2025
Same journal

Cannabis and Cannabidiol, GLP-1 Receptors, and Autophagy: The Burgeoning Link Between Cognitive Neurodegeneration With Alzheimer's Disease and Metabolic Disorders.

Discovery medicine·2026
Same journal

The Urgent Need to Assess and Prevent the Deposits of Microplastics and Nanoplastics in Our Brain.

Discovery medicine·2025
Same journal

Bridging the Translational Gap: Prioritizing the Spontaneous Canine Osteoarthritis Model for Preclinical Studies.

Discovery medicine·2025
Same journal

Harnessing the Power of Chlorogenic Acid: Inhibiting IL-2-Mediated Treg Upregulation to Combat Post-Traumatic Osteomyelitis.

Discovery medicine·2025
Same journal

The Relationship of <i>MAPK10P</i> Gene Polymorphism With P-Wave Peak Time and P-Wave Dispersion in Elderly Patients With Paroxysmal Atrial Fibrillation.

Discovery medicine·2025
Same journal

Curcumin Attenuates PD-L1-Positive Neutrophil-Induced T-Lymphocyte Apoptosis and Alleviates Lung Injury During Sepsis in Rats.

Discovery medicine·2025
See all related articles

Sublingual immunotherapy (SLIT) offers a safe and effective way to treat airborne allergies with rapid, lasting effects. This method improves patient adherence and prevents new allergic conditions like asthma.

Area of Science:

  • Allergy and Immunology
  • Immunotherapy
  • Respiratory Medicine

Background:

  • Sublingual immunotherapy (SLIT) is a modern approach to treating allergies.
  • It aims to improve patient treatment acceptance by reducing side effects compared to other methods.
  • SLIT is particularly relevant for airborne allergens.

Purpose of the Study:

  • To highlight the efficacy and safety of sublingual allergen immunotherapy.
  • To outline the benefits of SLIT for allergic rhinoconjunctivitis and asthma.
  • To establish SLIT as a viable treatment option for various age groups.

Main Methods:

  • The study reviews existing research on sublingual allergen extracts.
  • It compares the outcomes of SLIT with traditional treatments and subcutaneous immunotherapy.

More Related Videos

Intralymphatic Immunotherapy and Vaccination in Mice
07:33

Intralymphatic Immunotherapy and Vaccination in Mice

Published on: February 2, 2014

Antigenic Liposomes for Generation of Disease-specific Antibodies
10:31

Antigenic Liposomes for Generation of Disease-specific Antibodies

Published on: October 25, 2018

Related Experiment Videos

Last Updated: Jun 7, 2026

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections
16:56

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections

Published on: August 30, 2014

Intralymphatic Immunotherapy and Vaccination in Mice
07:33

Intralymphatic Immunotherapy and Vaccination in Mice

Published on: February 2, 2014

Antigenic Liposomes for Generation of Disease-specific Antibodies
10:31

Antigenic Liposomes for Generation of Disease-specific Antibodies

Published on: October 25, 2018

  • Data focuses on onset of action, treatment effect, duration of effect, preventive effects, and safety profile.

    • Main Results:

    • SLIT demonstrates a rapid onset of action, within seven days.
    • It provides a strong therapeutic effect, surpassing symptomatic treatments.
    • SLIT offers lasting effects post-treatment and prevents new sensitizations and asthma development.

    Conclusions:

    • Sublingual immunotherapy is an effective and safe treatment for moderate to severe allergic rhinoconjunctivitis, with or without asthma.
    • It is suitable for both adults and children over five years old.
    • Expert care from an allergologist is crucial for managing this complex condition.